Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Brent R. Logan PhD
Director, Professor
Department of Institute for Health and Equity
Division of Biostatistics

OFFICE ADDRESS:
Health Research Center
8701 Watertown Plank Rd
Milwaukee, WI 53226

EDUCATION:
08/1992 - 05/1996 B.S., Vanderbilt University, Nashville, TN
09/1996 - 06/1998 M.S., Northwestern University, Evanston, IL
06/1998 - 06/2001 Ph.D., Northwestern University, Evanston, IL

FACULTY APPOINTMENTS:
09/1999 - 06/2001 Lecturer, Dept. of Statistics, Northwestern University
01/2001 - 05/2001 Lecturer,, Dept. of Mathematics and Computer Science, Loyola University
08/2001 - 06/2006 Assistant Professor, Division of Biostatistics, Medical College of Wisconsin
08/2001 - 06/2006 Adjunct Assistant Professor, Department of Mathematics, University of Wisconsin-Milwaukee
07/2006 - 06/2011 Associate Professor,, Institute for Health and Society, Division of Biostatistics, Medical College of Wisconsin
07/2006 - 06/2011 Adjunct Associate Professor, Department of Mathematics, University of Wisconsin-Milwaukee
07/2011 - Present Professor,, Institute for Health and Society, Division of Biostatistics, Medical College of Wisconsin
07/2011 - Present Adjunct Professor, Department of Mathematics, University of Wisconsin-Milwaukee

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
* Denotes invited talks.
*Logan, BR, Tamhane, AC. "Multiple Test Procedures for Identifying the Minimum Effective and Maximum Safe Doses of a Drug, " Division of Biostatistics Seminar Series
*Logan, BR, Tamhane, AC. "Multiple Test Procedures for Identifying the Minimum Effective and Maximum Safe Doses of a Drug, " Department of Mathematics Seminar Series, Illinois State University, Bloomington-Normal
*Logan, BR, Tamhane, AC. "Multiple Test Procedures for Identifying the Minimum Effective and Maximum Safe Doses of a Drug, " Division of Biostatistics Seminar Series, Tulane University, New Orleans
*Logan, BR, Zhang, M.-J., and Wang, H. "Pairwise Multiple Comparison Adjustment in Survival Analysis, " Division of Biostatistics Seminar Series, Medical College of Wisconsin, Milwaukee
*Logan, BR, Geliazkova, MP "An evaluation of spatial thresholding procedures in fMRI analysis", Department of Mathematics, Statistics, and Computer Science Seminar Series, Marquette University, Milwaukee
*Logan, BR, Zhang M-J, Klein JP. Marginal models for clustered time to event data with competing risks using pseudo-values. Department of Biostatistics Seminar Series
*Logan, BR, Zhang M-J, Klein JP. Marginal models for clustered time to event data with competing risks using pseudo-values. Division of Biostatistics Seminar Series
*Logan, BR "Issues in clinical trials in hematopoietic cell transplantation." Office of Oncological Drug Products
*Logan, BR. Multiple Testing Workshop. Milwaukee Chapter of the ASA Fall Meeting, Milwaukee
*Logan, BR. Group sequential methods for comparing late differences in survival curves. Office of Oncological Drug Products
*Logan, BR, Zhang M-J, Klein JP. Marginal models for clustered time to event data with competing risks using pseudo-values. Department of Statistics Seminar Series
 
Regional
*Logan, BR, Zhang, M.-J., and Wang, H. "Pairwise Multiple Comparison Adjustment in Survival Analysis, " Fall meeting of the Northeastern Illinois Chapter, American Statistical Association, Skokie
*Logan, BR, Pasquini MC, Nietfeld, JJ, Verter, F, Horowitz, MM. "Estimating the lifetime likehood that a person might use their umbilical cord blood if it is stored at birth, " Conference on Teaching Elementary Statistics, sponsored by the Division of Biostatistics, Medical College of Wisconsin, Milwaukee
 
National
*Logan, BR and Tamhane, AC "Multiple Test Procedures for Identifying the Minimum Effective and Maximum Safe Doses of a Drug, " 6th Great Lakes Symposium on Applied Statistics, Kalamazoo
*Logan, BR and Rowe, D.B. "Thresholding Methods in FMRI Analysis Using the False Discovery Rate: An Investigation into the Impact of Spatial Correlation, " 2003 Human Brain Mapping Conference, New York City
Logan, BR, Zhang, M.-J., and Wang, H. "Pairwise multiple comparison adjustment in survival analysis, " 2003 Joint Statistical Meetings, San Francisco
Logan, BR, Geliazkova, M. "Measuring the size of a region of activation in fMRI analysis, " 2005 Joint Statistical Meetings, Minneapolis
*Logan, BR. "Getting the most out of journal articles, " 2005 NMDP Council Meeting, Minneapolis
*Logan, BR and Majhail, Navneet. "Getting the most out of your journal articles, " 2007 NMDP Council Meeting, Minneapolis
*Logan, BR "Phase II and III Study Designs for aGVHD, " Workshop on Clinical Trial Endpoints for Acute Graft-vs-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation, Washington
 
International
Logan, BR and Tamhane, AC "Combining global and marginal tests to compare two treatments on multiple endpoints, " International Conference on Multiple Comparison Procedures, Berlin
*Logan, BR "Statistical Issues in Clinical Trials, " 2002 Tandem BMT Meetings, Orlando
*Logan, BR "Statistical Issues in Clinical Trials, " 2003 Tandem BMT Meetings, Keystone
*Logan, BR "Biological Assignment Trials in Bone Marrow Transplantation, " 2003 Tandem BMT Meetings, Keystone
*Logan, BR "Clinical Research Methodology Workshop: Design, Development, Analysis and Interpretation of Studies with Focus in Tranplantation, " 10th Brazilian Congress on Bone Marrow Transplantation, Curitiba
*Logan, BR. "Thresholding and the Multiple Testing Problem", Human Brain Mapping Conference, Chicago
Logan, BR, Geliazkova, MP, Laud, PW, Rowe, DB. "A Bayesian spatial mixture model for fMRI data." International Conference on Multiple Comparison Procedures, Vienna
*Logan, BR "ASBMT Clinical Research Training Course." Faculty participant and presenter, Keystone
*Logan, BR "ASBMT Clinical Research Training Course." Faculty participant and presenter, Keystone
*Logan, BR "Beyond the standard phase II clinical trial, " 2009 Tandem BMT Meetings, Tampa Bay
*Logan, BR "ASBMT Clinical Research Training Course." Faculty participant and presenter, Keystone
*Logan, BR "Statistical Design of Clinical Trials: How best to answer your question." 2010 Tandem BMT Meetings, Orlando
*Logan, BR "Cox proportional hazards model using SAS." Short course, 2010 Tandem BMT Meetings, Orlando
*Logan, BR "ASBMT Clinical Research Training Course." Faculty participant and presenter, Keystone
*Logan, BR "Overview of bias in observational studies using registry databases." 2011 EBMT Meetings, Paris
Logan, BR "Long-term survival comparisons with covariate adjustment using a registry database." 2011 International Society for Clinical Biostatistics, Ottawa
Logan, BR "A cone order monotone test for the one-sided multiple endpoint problem, " International Conference on Multiple Comparison Procedures, Washington, D.C.
 


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Logan, B.R., Tamhane, A.C.: Combining global and marginal tests to compare two treatments on multiple endpoints. Biometrical Journal, 43: 591-604, 2001.
2. Chang, C.-C., Lorek, J., Chitambar, C.R., Logan, B., Kampalath, B., Cleveland, R. Expression of MUM1/IRF4 correlates with clinical outcome in patients with B-cell chronic lymphocytic leukemia. Blood, 100: 4671-4675, 2002.
3. Drobyski, W.R., Komorowski, R., Logan, B., Gendelman, M.: Role of the passive apoptotic pathway in graft-versus-host disease. Journal of Immunology, 169: 1626-1633, 2002.
4. Nicolosi, A.C., West, G., Markley, J. G., Logan, B., Olinger, G. N.: Gadolinium attenuates regional stunning in the canine heart in vivo. J Thorac Cardiovasc Surg,124:57-62, 2002.
5. Tamhane, A.C., Logan, B.R.: Multiple test procedures for identifying the minimum effective and maximum safe doses of a drug. Journal of the American Statistical Association, 97: 293-301, 2002.
6. Tamhane, A.C., Logan, B.R.: Accurate critical constants for the one-sided approximate likelihood ratio test of a normal mean vector when the covariance matrix is estimated. Biometrics, 58: 650-656, 2002.
7. Chang, C.-C., Kampalath, B., Schultz, C., Bunyi-Teopengco, E., Logan, B., Eshoa, C., Dincer, A.P., Perkins, S.L. Expression of p53 or c-Myc suggests a poor prognosis in primary central nervous system diffuse large B-cell lymphoma among immunocompetent individuals. Archives of Pathology & Laboratory Medicine, 127: 208-212, 2003.
8. Logan, B.R. A cone order monotone test for the one-sided multivariate testing problem. Statistics and Probability Letters, 63: 315-323, 2003.
9. Chang, C.-C., Bredeson, C., Juckett, M., Logan, B., Keever-Taylor, C. A. Tumor load in patients with follicular lymphoma post stem cell transplantation may correlate with clinical course. BMT, 32:287-291, 2003.
10. Hurley, C., Baxter-Lowe, L.A., Logan, B., Karanes, C., Anasetti, C., Weisdorf, D., Confer, D.L. National Marrow Donor Program HLA matching guidelines for unrelated marrow transplants. Biology of Blood and Marrow Transplantation, 9:610-615, 2003.
11. Gendelman, M., Hecht, T., Logan, B., Vodanovic-Jankovic, S., Komorowski, R., and Drobyski, W.R. Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease. Journal of Immunology, 172: 3328 - 3336, 2004.
12. Lyon, R.M., Liu, X.-C., Thometz, J., and Logan, B. Reproducibility of measurements of spinal back contour using Raster stereography in patients with adolescent idiopathic scoliosis. American Journal of Orthopedics, 33:67-70, 2004.
13. Logan, B.R. and Rowe, D.B. An evaluation of thresholding techniques in fMRI analysis. NeuroImage, 22: 95-108, 2004.
14. Chang, C.-C., McClintock, S., Cleveland, R.P., Trzpuc, T., Chitambar, C.R., Logan, B., Balla, A., Kampalath, B., and Perkins, S.L. Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma. American Journal of Surgical Pathology, 28: 464-470, 2004.
15. Logan, B.R. and Tamhane, A.C. On O'Brien's OLS and GLS tests for multiple endpoints. Recent Developments in Multiple Comparison Procedures, IMS Lecture Notes - Monograph Series 47:76-88, 2004.
16. Tamhane, A.C. and Logan, B.R. A superiority-equivalence approach to one-sided tests on multiple endpoints in clinical trials. Biometrika, 91: 715-727, 2004.
17. Rowe, D.B. and Logan, B.R. A complex way to compute fMRI activation. NeuroImage, 23: 1078-1092, 2004.
18. Tamhane, A.C. and Logan, B.R. Finding the maximum safe dose level for heteroscedastic data. Journal of Biopharmaceutical Statistics, 14: 843-856, 2004.
19. Hari, P., Logan, B., and Drobyski, W.R. Temporal discordance between graft-versus leukemia and graft-versus-host responses: A strategy for the separation of graft-versus-leukemia/graft-versus-host reactivity? Biology of Blood and Marrow Transplantation, 10: 743-747, 2004.
20. Lee, S.J., Loberiza, F.R., Antin, J.H., Kirkpatrick T., Prokop L., Alyea, E.P., Cutler, C., Ho, V.T., Richardson, P.G., Schlossman, R.L., Fisher, D.C., Logan, B., and Soiffer, R.J. Routine screening for psychosocial distress following hematopoietic stem cell transplantation. BMT, 35: 77-83, 2005.
21. Gendelman, M., Halligan, N., Komorowski, R., Logan, B., Murphy, W.J., Blazar, B.R., Pritchard, Jr., K.A., and Drobyski, W.R. Phenyl N-Tert-Butylnitrone (PBN) protects syngeneic marrow transplant recipients from the lethal cytokine syndrome occurring after agonistic CD40 antibody administration. Blood, 105: 428-431, 2005.
22. Rowe, D.B. and Logan, B.R. Complex fMRI analysis with unrestricted phase is equivalent to a magnitude-only model. Neuroimage, 24: 603-606, 2005.
23. Logan, B.R., Wang, H., and Zhang, M.-J. Pairwise multiple comparison adjustment in survival analysis. Statistics in Medicine, 24: 2509-2523, 2005.
24. Logan, B.R. Optimal two-stage randomized phase II clinical trials, Clinical Trials, 2: 5-12, 2005.
25. McGregor, D.K., Keever-Taylor, C.A., Schur, B., Vesole, D.H., Bredeson, C., Logan, B., Farkas, D.H., and Chang, C.-C. The implication of follicular lymphoma patients receiving allogeneic stem cell transplantation from donors carrying t(14;18) positive cells. BMT, 35: 1049-1054, 2005.
26. Starsky, A.J., Sangani, S.G., McGuire, J.R., Logan, B., and Schmit, B.D. Reliability of biomechanical spasticity measurements at the elbow of people post stroke. Archives of Physical Medicine and Rehabilitation, 86: 1648-1654, 2005.
27. Shidham, G.B., Siddiqi, N., Beres, J.A., Logan, B., Nagaraja, H., Shidham, S.G., and Piering, W.F. Clinical risk factors associated with bleeding after native kidney biopsy. Nephrology, 10: 305-310, 2005.
28. Logan, B.R., Zhang, M.-J., and Klein, J.P. Regression models for hazard rates versus cumulative incidence probabilities in bone marrow transplant data. Biology of Blood and Marrow Transplantation, 12: 107-112, 2006.
29. Kovach, C. R., Logan, B., Noonan, P. E., Schlidt, A. M., Smerz, J., Simpson, M., & Wells, T. Effects of the Serial Trial Intervention on discomfort and behavior in demented nursing home residents. American Journal of Alzheimer's Disease, 21: 147-155, 2006.
30. Rhee, J.S., Matthews, B.A., Neuburg, M., Logan, B.R., Burzynski, M., Nattinger, A.B. Validation of a quality of life scale for patients with nonmelanoma skin cancer. Archives of Facial Plastic Surgery, 8: 314-318, 2006.
31. Rhee, J.S., Matthews, B.A., Neuburg, M., Logan, B.R., Burzynski, M., Nattinger, A.B. The Skin Cancer Index: Clinical Responsiveness and Predictors of Quality of Life. Laryngoscope, 117: 399-405, 2007.
32. Klein, J.P., Logan, B., Harhoff, M. and Andersen, P.K. Analyzing survival curves at a fixed point in time. Statistics in Medicine, 26: 4505-4519, 2007.
33. Lazarus, H.M., Stiff, P.J., Carreras, J., Logan, B.R., Akard, L., Bolwell, B.J., Childs, R.W., Gale, R.P., Klein, J.P., Lill, M.C., Perez, W.S., Stadtmauer, E.A., Rizzo, J.D. Utility of single versus tandem autotransplants for advanced testes/germ cell cancer: A Center for International Blood & Marrow Transplant Research (CIBMTR) Analysis. Biology of Blood and Marrow Transplantation, 13: 778-789, 2007.
34. Tallman, M.S., Dewald, G.W., Gandham, S., Logan, B.R., Keating, A., Lazarus, H.M., Litzow, M.R., Mehta, J., Pedersen, T., Perez, W.S., Rowe, J.M., Wetzler, M., Weisdorf, D.J. Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission. Blood, 110: 409-417, 2007.
35. Giralt, S., Logan, B., Rizzo, D., Zhang, M.-J., Ballen, K., Emmanouilides, C., Nath, R., Parker, P., Porter, D., Sandmaier, B., Waller, E., Barker, J., Pavletic, S. Weisdorf, D. Long Term Follow Up of Reduced Intensity Conditioning Regimens With Volunteer Unrelated Donor Progenitor Cell Transplantation: Lessons Learned From the First 285 Patients Reported to the National Marrow Donor Program. An Analysis from the Center for International Blood and Marrow Transplant Research. Biology of Blood and Marrow Transplantation, 13: 844-852, 2007.
36. Gorski, J, Chen, X., Gendelman, M., Yassai, M., Krueger, A., Tivol, E., Logan, B., Komorowski, R., Vodanovic-Jankovic, S., Drobyski, W.R. Homeostatic expansion and repertoire regeneration of donor T cells during graft versus host disease is constrained by the host environment. Blood, 109: 5502-5510, 2007.
37. Nicolosi A.C., Kwok, C.S., Logan, B.R. Effects of gadolinium on regionally stunned myocardium: temporal considerations. Journal of Surgical Research, 139: 286-291, 2007
38. Eapen, M.E., Logan, B.R., Confer, D.L., Haagenson, M., Wagner, J.E., Weisdorf, D.J., Wingard, J.R., Rowley, S.D., Stroncek, D., Gee, A.P., Horowitz, M.M., Anasetti, C. Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. Biology of Blood and Marrow Transplantation, 13: 1461-1468, 2007.
39. Kamani, N., Spellman, S., Hurley, C.K., Barker, J.N., Smith, F.O., Oudshoorn, M., Bray, R., Smith, A., Williams, T.M., Logan, B., Eapen, M., Anasetti, C., Setterholm, M., Confer, D.L. State of the Art Review: HLA Matching and Outcome of Unrelated Donor Umbilical Cord Blood Transplants. Biology of Blood and Marrow Transplantation, 14: 1-6, 2008.
40. Nietfeld, J.J., Pasquini, M.P., Logan, B.R., Verter, F., Horowitz, M.M. Lifetime probabilities of hematopoietic stem cell transplantation in the US. Biology of Blood and Marrow Transplantation, 14: 316-322, 2008.
41. Howard, D.H., Meltzer, D., Kollman, C., Maiers, M., Logan, B., Gragert, L., Setterholm, M., Horowitz, M.M. Use of cost-effectiveness analysis to determine inventory size for a national cord blood bank. Medical Decision Making, 28: 243-253, 2008.
42. Rhee, J.S., Davis-Malesevich, M., Logan, B.R., Neuburg, M., Burzynski, M., Nattinger, A.B. Behavior Modification and Risk Perception in patients with Nonmelanoma Skin Cancer. Wisconsin Medical Journal, 107: 62-68, 2008.
43. Bishop, M.R., Logan, B.R., Gandham, S., Bolwell, B.J., Cahn, J.-Y., Lazarus, H.M., Litzow, M.R., Marks, D.I., Wiernik, P.H., McCarthy, P.L., Russell, J.A., Miller, C., Sierra, J., Milone, G., Keating, A., Loberiza, F.R., Giralt, S.A., Horowitz, M.M., Weisdorf, D.J. Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research. Bone Marrow Transplant, 41: 635-642, 2008.
44. Logan, B.R., Klein, J.P., and Zhang, M.-J. Comparing treatments in the presence of crossing survival curves: an application to bone marrow transplantation. Biometrics, 64: 733-740, 2008.
45. Logan, B.R. and Tamhane, A.C. Superiority inferences on individual endpoints following non-inferiority testing in clinical trials. Biometrical Journal, 50: 693-703, 2008.
46. Liu, L., Logan, B., Klein, J.P. Inference for current leukemia free survival. Lifetime Data Analysis, 14: 432-446, 2008.
47. Logan, B.R., Nelson, G.O., Klein, J.P. Analyzing center specific outcomes in hematopoietic cell transplantation. Lifetime Data Analysis, 14: 389-404, 2008.
48. Logan, B.R., Geliazkova, M.P., Rowe, D.B. An evaluation of spatial thresholding techniques in fMRI analysis. Human Brain Mapping, 29: 1379-1389, 2008
49. Logan, B.R., Leifer E.S., Bredeson, C., Horowitz, M.M., Ewell, M., Carter, S., Geller, N. Use of biological assignment in hematopoietic stem cell transplantation clinical trials. Clinical Trials, 5: 607-616, 2008.
50. Devetten, M.P., Hari, P.N., Carreras, J., Logan, B.R., van Besien, K., Bredeson, C.N., Freytes, C.O., Gale, R.P., Gibson, J., Giralt, S.A., Goldstein, S.C., Gupta, V., Marks, D.I., Maziarz, D.I., Vose, J.M., Lazarus, H.N., and Anderlini, P. Unrelated Donor Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma, Biology of Blood and Marrow Transplantation, 15: 109-117, 2009.
51. Tunes da Silva, G., Logan, B.R., and Klein, J.P. Methods for equivalence and non-inferiority testing. Biology of Blood and Marrow Transplant, 15 (S): 120-127, 2009.
52. Gale, R.P., Eapen, M., Logan, B., Zhang, M.-J., Lazarus, H. Comparing Therapy-Options: Are Observational Database Studies and Expert Opinion As Good (or Better) Than Randomized Controlled Trials? Bone Marrow Transplantation, 43: 435-446, 2009.
53. Pulsipher, M.A., Chitphakdithai, P., Miller, J., Logan, B., King, R., Rizzo, D., Leitman, S.F., Anderlini, P., Haagenson, M., Kurian, S., Klein, J., Horowitz, M.M., Confer, D.L. Adverse events among 2408 unrelated donors of peripheral blood stem cells: Results of a prospective trial from the National Marrow Donor Program. Blood, 113: 3604-3611, 2009.
54. Ratanatarathorn, V., Logan, B., Wang, D., Horowitz, M., Uberti, J.P., Ringden, O., Gale, R.P., Khoury, H., Arora, M., Spellman, S., Cutler, C., Antin, J., Bornhauser, M., Hale, G., Verdonck, L., Cairo, M., Gupta, V., Pavletic, S. Prior rituximab correlated with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation (PBSCT). British Journal of Hematology, 145: 816-824, 2009.
55. Van Besien, K., Carreras, J., Bierman, P.J., Logan, B.R., Molina, A., King, R., Nelson, G., Fay, J.W., Champlin, R.E., Lazarud, H.M., Vose, J.M., Hari, P.N. Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes, Biology of Blood and Marrow Transplantation, 15: 554-563, 2009.
56. Alousi, A.M., Weisdorf, D.J., Logan, B.R., Bolanos-Meade, J., Carter, S., DiFronzo, N., Pasquini, M., Goldstein, S.C., Ho, V.T., Hayes-Lattin, B., Wingard, J.R., Horowitz, M.M., and Levine, J.E. Etanercept, Mycophenolate, Denileukin or Pentostatin plus Corticosteroids for Acute Graft vs. Host Disease: A Randomized Phase II Trial from the BMT CTN. Blood, 114: 511-517, 2009.
57. Marks, D.I., Ballen, K., Logan, B.R., Wang, Z., Sobocinski, K., Bacigalupo, A., Burns, L.J., Gupta, V., Ho, V., McCarthy, P.L., Ringden, O., Schouten, H.C., Seftel, M., Rizzo, J.D. The effect of smoking on allogeneic transplant outcomes. Biology of Blood and Marrow Transplantation, 15: 1277-1287, 2009.
58. Pulsipher, M.A., Chitphakdithai, P., Logan, B.R., Leitman, S., Anderlini, P., Klein, J.P., Horowitz, M.M., Miller, J.P., King, R.J., Confer, D.L. Donor, Recipient, and Transplant Characteristics as Risk Factors after Unrelated Donor PBSC Transplantation: Beneficial Effects of Higher CD34+ Cell Dose, Blood, 114: 2606-2616, 2009.
59. Curry, C.V., Ewton, A.A., Olsen, R.J., Logan, B.R., Preti, H.A., Liu, Y.C., Perkins, S.L., and Chang, C.C., Prognostic impact of C-REL expression in diffuse large B-cell lymphoma, Journal of Hematopathology; 2(1):20-6, 2009.
60. Kovach, C.R., Logan, B.R., Simpson, M., & Reynolds, S. Factors Associated with Time to Identify Physical Problems of Nursing Home Residents with Dementia. American Journal of Alzheimer's Disease & Other Dementias, 25: 317-323, 2010.
61. Jacobson, P.A., Huang, J., Wu, J., Kim, M., Logan, B., Alousi, A., Grimley, M., Bolaños-Meade, J., Ho, V., Levine, J.E., Weisdorf, D. Mycophenolate Pharmacokinetics and Association with Response to Acute Graft-versus-Host Disease Treatment from the Blood and Marrow Transplant Clinical Trials Network. Biology of Blood and Marrow Transplantation, 16: 421-429, 2010.
62. Schriber, J., Agovi, M.-A., Ho, V., Ballen, K.K., Bacigalupo, A., Lazarus, H.M., Bredeson, C.N., Gupta, V., Maziarz, R.T., Hale, G.A., Litzow, M.R., Logan, B., Bornhauser, M., Giller, R.H., Isola, L., Marks, D.I., Rizzo, J.D., Pasquini, M.C. Second unrelated donor hematopoietic cell transplantation for primary graft failure. Biology of Blood and Marrow Transplantation, 16: 1099-1106, 2010.
63. Navarro WH, Agovi MA, Logan B, Bacigalupo A, Ballen KK, Bolwell BJ, Frangoul H, Gupta V, Hahn T, Ho VT, Juckett M, Lazarus HM, Litzow MR, Liesveld J, Moreb J, Marks D, McCarthy PL, Rizzo JD, Pasquini MC. Obesity Does Not Preclude Safe and Effective Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in Adults. Biology of Blood and Marrow Transplantation, 16:1445-1450, 2010.
64. Gupta V, Tallman MS, He W, Logan BR, Copelan E, Gale RP, Khoury HJ, Klumpp T, Koreth J, Lazarus HM, Rowe JM, Sabloff M, Waller E, DiPersio JF, Bunjes DW, Weisdorf DJ. Comparable survival after HLA-well matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis. Blood, 116: 1839-1848, 2010.
65. Levine JE, Logan B, Wu J, Alousi A, Ho V, Bolanos-Meade J, Weisdorf D. GVHD Treatment: Predictors of survival. Biology of Blood and Marrow Transplantation, 16: 1693-1699, 2010.
66. Logan, B.R., Zhang, M.-J., Klein, J.P. Marginal models for clustered time to event data with competing risks using pseudovalues. Biometrics, 67: 1-7, 2011.
67. Sabloff M, Chandy M, Wang Z, Logan BR, Ghavamzadeh A, Li C-K, Irfan SM, Bredeson CN, Cowan MJ, Gale RP, Hale GA, Horan J, Hongeng S, Eapen M, Walters MC. HLA-matched Sibling Bone Marrow Transplantation for -Thalassemia major. Blood, 117: 1745-1750, 2011.
68. Horan J, Logan BR, Agovi M, Lazarus HM, Bacigalupo A, Ballen KK, Bredeson CN, Carabasi MH, Gupta V, Hale GA, Khoury HJ, Juckett MB, Litzow MR, Martino R, McCarthy PL, Smith FO, Rizzo JD, Pasquini MC. Reducing The Risk For Transplant-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: How Much Progress Has Been Made? Journal of Clinical Oncology, 29: 805-813, 2011.
69. Kovach CR, Woods DL, Logan BR, Raff H. Diurnal Variation of Cortisol in People with Dementia: Relationship to Cognition and Illness Burden. American Journal of Alzheimer's Disease & other Dementias, 26: 145-150, 2011.
70. Barker CC, Agovi MA, Logan B, Pasquini M, Gupta V, Lazarus HM, Hale G and Frangoul H. Childhood Obesity Adversely Affects Survival and Mortality in Pediatric Non-Cancer Hematopoietic Cell Transplant Recipients with Aplastic Anemia. Biology of Blood and Marrow Transplantation, 17: 737-744, 2011.
71. Kovach CR, Logan BR, Joosse LL, Noonan PE. Failure to Identify Behavioral Symptoms of People with Dementia and the Need for Follow-Up Physical Assessment. Research in Gerontological Nursing, 5: 89-93, 2012.
72. Krishnan A, Pasquini MC, Logan B, Stadtmauer EA, Vesole DH, Alyea E, Antin JH, Comenzo R, Goodman S, Hari P, Laport G, Qazilbash MH, Rowley S, Sahebi F, Somlo G, Vogl DT, Weisdorf D, Ewell M, Wu J, Geller NL, Horowitz MM, Giralt S, Maloney DG. (In press) Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial. Lancet Oncology, 12: 1195-1203, 2011.
73. Thiel EL, Zhang M-J, Davies SM, Camitta BM, Logan B, Tiedemann K, Eapen M. (In press) Comparison of Outcomes after HLA-matched Sibling and Unrelated Donor Transplantation for Children with High-Risk Acute Lymphoblastic Leukemia. Bone Marrow Transplant.
74. Kovach CR, Simpson MR, Joosse LL, Logan BR, Noonan PE, Reynolds SA, Woods DL, Raff H(In press) Comparison of the Effectiveness of Two Protocols for Treating Nursing Home Residents with Advanced Dementia. Research in Gerontological Nursing.
75. Levine JE, Logan BR, Wu J, Alousi AM, Meade JB, Ferrara JLM, Ho VT, Weisdorf DJ, Paczesny S. (In press) Acute Graft-Versus-Host Disease Biomarkers Measured During Therapy Can Predict Treatment Outcomes: A Blood and Marrow Transplant Clinical Trials Network Study, Blood.
76. Kamani NR, Walters MC, Carter S, Aquino V, Brochstein JA, Chaudhury S, Eapen M, Freed BM, Grimley M, Levine JE, Logan B, Moore T, Panepinto J, Parikh S, Pulsipher MA, Sande J, Schultz KR, Spellman S, Shenoy S. (In press) Unrelated Donor Cord Blood Transplantation for Children with Severe Sickle Cell Disease: Results of One Cohort from the Phase II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). Biology of Blood and Marrow Transplantation.
77. Spellman S, Eapen M, Logan B, Mueller C, Rubinstein P, Setterholm M, Woolfrey A, Horowitz MM, Confer DL, Hurley CK. (In press) A Perspective on the Selection of Unrelated Donors and Cord Blood Units for Transplantation. Blood.
78. Logan BR, Zhang M-J. (In press) The use of group sequential designs with common competing risks tests. Statistics in Medicine.
79. Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, Cutler CS, Westervelt P, Woolfrey A, Couban S, Ehninger G, Johnston L, Maziarz RT, Pulsipher MA, Porter DL, Mineishi S, McCarty JM, Khan SP, Anderlini P, Bensinger WI, Leitman SF, Rowley SD, Bredeson C, Carter SL, Horowitz MM, Confer DL. (In press) Peripheral blood stem cells versus bone marrow from unrelated donors. New England Journal of Medicine.
80. Pulsipher MA, Chitphakdithai P, Logan B, et al. (In press). Acute Toxicities of Unrelated Bone Marrow versus Peripheral Blood Stem Cell Donation: Results of a Prospective Trial from the NMDP. Blood.
81. Martens MJ, Logan BR. A group sequential test for treatment effect based on the Fine-Gray model. Biometrics. 2018 09;74(3):1006-1013. PMCID: PMC6146968
82. Miggelbrink AM, Logan BR, Buckley RH, Parrott RE, Dvorak CC, Kapoor N, Abdel-Azim H, Prockop SE, Shyr D, Decaluwe H, Hanson IC, Gillio A, Dávila Saldaña BJ, Eibel H, Hopkins G, Walter JE, Whangbo JS, Kohn DB, Puck JM, Cowan MJ, Griffith LM, Haddad E, O'Reilly RJ, Notarangelo LD, Pai SY. B-cell differentiation and IL-21 response in SCID patients after hematopoietic stem cell transplantation. Blood. 2018 Jun 28;131(26):2967-2977. PMCID: PMC6024640
83. Wang Y, Logan BR. Testing for center effects on survival and competing risks outcomes using pseudo-value regression. Lifetime Data Anal. 2018 Jul 05. PMCID: PMC6320737
84. Carpenter PA, Logan BR, Lee SJ, Weisdorf DJ, Johnston L, Costa LJ, Kitko CL, Bolaños-Meade J, Sarantopoulos S, Alousi AM, Abhyankar S, Waller EK, Mendizabal A, Zhu J, O'Brien KA, Lazaryan A, Wu J, Nemecek ER, Pavletic SZ, Cutler CS, Horowitz MM, Arora M, BMT CTN.. A phase II/III randomized, multicenter trial of prednisone/sirolimus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft--host disease: BMT CTN 0801. Haematologica. 2018 Nov;103(11):1915-1924. PMCID: PMC6278959
85. Jacobsohn DA, Loken MR, Fei M, Adams A, Brodersen LE, Logan BR, Ahn KW, Shaw BE, Kletzel M, Olszewski M, Khan S, Meshinchi S, Keating A, Harris A, Teira P, Duerst RE, Margossian SP, Martin PL, Petrovic A, Dvorak CC, Nemecek ER, Boyer MW, Chen AR, Davis JH, Shenoy S, Savasan S, Hudspeth MP, Adams RH, Lewis VA, Kheradpour A, Kasow KA, Gillio AP, Haight AE, Bhatia M, Bambach BJ, Haines HL, Quigg TC, Greiner RJ, Talano JM, Delgado DC, Cheerva A, Gowda M, Ahuja S, Ozkaynak M, Mitchell D, Schultz KR, Fry TJ, Loeb DM, Pulsipher MA. Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression. Biol Blood Marrow Transplant. 2018 Oct;24(10):2040-2046. PMCID: PMC6239928
86. Knight JM, Kerswill SA, Hari P, Cole SW, Logan BR, D'Souza A, Shah NN, Horowitz MM, Stolley MR, Sloan EK, Giles KE, Costanzo ES, Hamadani M, Chhabra S, Dhakal B, Rizzo JD. Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation. BMC Cancer. 2018 May 24;18(1):593. PMCID: PMC5968588
87. Haddad E, Logan BR, Griffith LM, Buckley RH, Parrott RE, Prockop SE, Small TN, Chaisson J, Dvorak CC, Murnane M, Kapoor N, Abdel-Azim H, Hanson IC, Martinez C, Bleesing JJH, Chandra S, Smith AR, Cavanaugh ME, Jyonouchi S, Sullivan KE, Burroughs L, Skoda-Smith S, Haight AE, Tumlin AG, Quigg TC, Taylor C, Dávila Saldaña BJ, Keller MD, Seroogy CM, Desantes KB, Petrovic A, Leiding JW, Shyr DC, Decaluwe H, Teira P, Gillio AP, Knutsen AP, Moore TB, Kletzel M, Craddock JA, Aquino V, Davis JH, Yu LC, Cuvelier GDE, Bednarski JJ, Goldman FD, Kang EM, Shereck E, Porteus MH, Connelly JA, Fleisher TA, Malech HL, Shearer WT, Szabolcs P, Thakar MS, Vander Lugt MT, Heimall J, Yin Z, Pulsipher MA, Pai SY, Kohn DB, Puck JM, Cowan MJ, O'Reilly RJ, Notarangelo LD. SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery. Blood. 2018 Oct 25;132(17):1737-1749. PMCID: PMC6202916
88. Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Parameswaran V, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Confer DL, Shaw BE. Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at 1-year compared to unrelated donors. Haematologica. 2018 Oct 31.
89. Pulsipher MA, Logan BR, Chitphakdithai P, Kiefer DM, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Bunin NJ, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Shaw BE, Confer DL. Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study. Biol Blood Marrow Transplant. 2018 Nov 10.
90. Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Ball ED, Bolwell BJ, Bunin NJ, Cheerva A, Delgado DC, Dvorak CC, Gillio AP, Hahn TE, Hale GA, Haight AE, Hayes-Lattin BM, Kasow KA, Linenberger M, Magalhaes-Silverman M, Mori S, Prasad VK, Quigg TC, Sahdev I, Schriber JR, Shenoy S, Tse WT, Yanik GA, Navarro WH, Horowitz MM, Confer DL, Shaw BE, Switzer GE. Higher risks of toxicity and incomplete recovery in 13-17 year old females after marrow donation: RDSafe peds results. Biol Blood Marrow Transplant. 2018 Dec 31.
 
Books, Chapters, and Reviews
1. Logan, B.R.: Solutions manual for "Statistics and Data Analysis: From Elementary to Intermediate", by Ajit C. Tamhane and Dorothy D. Dunlop, Upper Saddle River: Prentice-Hall, 2000.
2. Howard, D.H., Maiers, M., Gragert, L., Setterholm, M., Kollman, C., and Logan, B. The impact of cord blood inventory size on patient survival time and costs. In E. Meyer, A. Pope, Eds. Report on Establishing a National Cord Blood Stem Cell Bank Program. Washington, D.C.: National Academies Press, 2005.
3. Tamhane, A.C. and Logan, B.R. Multiple comparison procedures for dose-response studies. In Dose Finding in Drug Development, (Ed. N. Ting), Birkhauser/Springer-Verlag, 2006.
 
Non-Refereed Journal Publications/Original Papers
1. Rowe, D.B. and Logan, B.R. An fMRI activation method using complex data. Proceedings of the International Society for Biomedical Imaging, #616, 2004.
2. Geliazkova, M.P. and Logan, B.R. Measuring the size of a region of activation in fMRI analysis. 2005 Proceedings of the American Statistical Association, Minneapolis, MN.
 
Abstracts
1. Uysal, N., Schapira, M.M., Brondino, M.J., Logan, B., Sidhu, J.K. A randomized clinical trial to test the effectiveness of risk communication on readiness to change among smokers in a primary care setting. ACCP Chest 2003 Meeting, Orlando, FL. Chest 2003; 124(45):230S.
2. Logan, B.R. and Rowe, D.B. (2004). A Comparison of fMRI activation thresholding methods. International Society for Magnetic Resonance in Medicine 2004 Meeting, Kyoto, Japan (05/2004). Proc. Intl. Soc. Magn. Reson. Med., 12, 1095.
3. Giralt, S., Logan, B., Zhang, M.J. et al. (2004). Non-ablative or reduced intensity conditioning regimen with volunteer unrelated donor progenitor cell transplantation. American Society of Hematologists Meeting, Blood, 104: 2751.
4. Wall, D., Wagner, J., Laughlin, M., Ballen, K., Staba, S., Chan, K.W., McGaha, O., Logan, B., et al. (2004). Higher cell dose and CD34+ content improves engraftment following unrelated donor cord blood transplantation (CBT): A report of the National Marrow Donor Program (NMDP) Cord Blood (CB) experience. American Society of Hematologists Meeting, Blood, 104: 975.
5. Tallman, M., Dewald, G., Lazarus, H., Gandham, S., Nelson, G., Logan, B., et al. (2004). Impact of cytogenetics on outcome of mismatched unrelated donor hematopoietic stem cell transplantation for adults with AML. American Society of Hematologists Meeting, Blood, 104: 830.
6. Howard, D.H., Meltzer, D., Kollman, C., Maiers, M., Logan, B., Gragert, L., Setterholm, M., Horowitz, M.M. (2005) Using cost-effectiveness analysis to design a national cord blood bank. Society for Medical Decision Making 2005 Meeting, San Francisco, CA (10/2005).
7. Pasquini, M.C., Logan, B.R., Verter, F., Horowitz, M.M., Nietfeld, J.J. (2005) The likelihood of hematopoietic stem cell transplantation (HCT) in the United States: Implications for umbilical cord blood storage. American Society of Hematologists Meeting, Blood, 106: 1330.
8. Pulsipher, M., Kurian, S., Leitman, S.F., Anderlini, P., Haagenson, M., Logan, B., et al. (2005) Unrelated-donor PBSC collection facilitated by the NMDP, 1999-2005: Efficacy and toxicities, serious unexpected events, and outcomes of standard vs. large volume collections. American Society of Hematologists Meeting, 106: 1965.
9. Eapen, M., Haagenson, M., Logan, B., et al. (2005) Use of peripheral blood grafts is associated with increased acute and chronic graft-versus-host disease without improved survival after unrelated donor transplantation. American Society of Hematologists Meeting, 106: 443.
10. Geliazkova, M.P. and Logan, B.R. (2006) ROC Analysis of spatial thresholding procedures in fMRI analysis. Submitted to Human Brain Mapping 2006, Abstract 619, Florence, Italy (06/2006).
11. Logan, B.R., Geliazkova, M.P., Laud, P.W., Rowe, D.B. (2007) A Bayesian spatial mixture model for fMRI analysis. Submitted to Human Brain Mapping 2007, Abstract 317, Chicago, IL (06/2007)
12. Alousi A, Weisdorf DJ, Logan BR, Meade JB, Goldstein SX, Ho VT, Hayes-Lattin B, Wingard JR, Horowitz MM, and Levine JE, BMT CTN 0302: A Phase II Randomized Trial Evaluating Etanercept, Mycophenolate Mofetil (MMF), Denileukin Diftitox, and Pentostatin in Combination with Corticosteroids in 180 Patients (pts) with Newly Diagnosed Acute Graft Vs. Host Disease (aGVHD), Blood (ASH Annual Meeting Abstracts), Nov 2008; 112: 55.
13. Navarro WH, Agovi MA, Logan B, Bacigalupo A, Ballen KK, Bolwell BJ, Frangoul H, Gupta V, Hahn T, Juckett M, Lazarus HM, Litzow MR, Liesveld J, Moreb J, Marks D, McCarthy PL, and Rizzo JD, Obesity Does Not Preclude Safe and Effective Myeloablative Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML) in Adults, Blood (ASH Annual Meeting Abstracts), Nov 2008; 112: 51.
14. Gupta V, Tallman MS, He W, Logan B, DiPersio JF, Bunjes DW, Weisdorf DJ. Comparable disease-free and overall survival after "well-matched" unrelated donor and matched sibling donor transplantation in acute myeloid leukemia with adverse risk karyotype in first Complete remission - a report from the Acute Leukemia Working Committee of the Centre for International Blood and Marrow Transplant Research. , Blood (ASH Annual Meeting Abstracts), Nov 2009; 114: 526.
15. Sabloff M, Chandy M,Wang Z, Logan B, Li C-K, Irfan SM, Eapen M, Walters MC. Bone marrow transplantation from HLA-identical sibling for Thalassemia, , Blood (ASH Annual Meeting Abstracts), Nov 2009; 114: 3361.
16. Horan, J Logan BR, Agovi M-A, Lazarus HM, Bacigalupo A, Ballen K, Martino R, Juckett MB, Khoury HJ, Bredeson C, Gupta V, Smith FO, Hale G, Carabasi M, McCarthy PL, Rizzo JD, Pasquini MC. Reducing the risk for transplant related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made? , Blood (ASH Annual Meeting Abstracts), Nov 2009; 114: 649.
17. Barker CC, Agovi M-A, Logan B, Gupta V, Lazarus HM, Ballen KK, Hale GA, Frangoul H, Rizzo JD, Pasquini MC. Obesity adversely affects survival of pediatric patients with severe aplastic anemia after hematopoietic cell transplantation, , Blood (ASH Annual Meeting Abstracts), Nov 2009; 114: 652.
 

jenkins-FCD Prod-296 4db9d02597e0a2e889e230f853b641c12f1c3ee3